These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1486241)

  • 1. The nuclear serine/threonine protein kinase DNA-PK.
    Anderson CW; Lees-Miller SP
    Crit Rev Eukaryot Gene Expr; 1992; 2(4):283-314. PubMed ID: 1486241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.
    McKendrick L; Meek DW
    Cell Mol Biol Res; 1994; 40(5-6):555-61. PubMed ID: 7735330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation by DNAPK inhibits the DNA-binding function of p53/T antigen complex in vitro.
    Sheppard HM; Liu X
    Anticancer Res; 1999; 19(3A):2079-83. PubMed ID: 10470151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of p53 protein in response to ionizing radiation occurs at multiple sites in both normal and DNA-PK deficient cells.
    Abraham J; Spaner D; Benchimol S
    Oncogene; 1999 Feb; 18(8):1521-7. PubMed ID: 10102621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
    Müller E; Boldyreff B; Scheidtmann KH
    Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage.
    Jimenez GS; Bryntesson F; Torres-Arzayus MI; Priestley A; Beeche M; Saito S; Sakaguchi K; Appella E; Jeggo PA; Taccioli GE; Wahl GM; Hubank M
    Nature; 1999 Jul; 400(6739):81-3. PubMed ID: 10403253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation and autoregulation of DNA-PK from structured single-stranded DNA and coding end hairpins.
    Soubeyrand S; Torrance H; Giffin W; Gong W; Schild-Poulter C; Haché RJ
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9605-10. PubMed ID: 11481441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DNA-activated protein kinase, DNA-PK: a potential coordinator of nuclear events.
    Lees-Miller SP; Anderson CW
    Cancer Cells; 1991 Sep; 3(9):341-6. PubMed ID: 1751287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates the tumor suppressor protein p53.
    Müller E; Scheidtmann KH
    Oncogene; 1995 Mar; 10(6):1175-85. PubMed ID: 7700642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific DNA binding by p53 is independent of mutation at serine 389, the casein kinase II site.
    Rolley N; Milner J
    Oncogene; 1994 Oct; 9(10):3067-70. PubMed ID: 8084615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-dependent protein kinase acts upstream of p53 in response to DNA damage.
    Woo RA; McLure KG; Lees-Miller SP; Rancourt DE; Lee PW
    Nature; 1998 Aug; 394(6694):700-4. PubMed ID: 9716137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structured DNA promotes phosphorylation of p53 by DNA-dependent protein kinase at serine 9 and threonine 18.
    Soubeyrand S; Schild-Poulter C; Haché RJ
    Eur J Biochem; 2004 Sep; 271(18):3776-84. PubMed ID: 15355354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53.
    Sugikawa E; Yazaki N; Tsunoda S; Nakanishi N; Ohashi M
    Biochem Biophys Res Commun; 1999 Aug; 261(2):256-63. PubMed ID: 10425175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OK-1035, a selective inhibitor of DNA-dependent protein kinase.
    Take Y; Kumano M; Hamano Y; Fukatsu H; Teraoka H; Nishimura S; Okuyama A
    Biochem Biophys Res Commun; 1995 Oct; 215(1):41-7. PubMed ID: 7575620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation.
    Kapoor M; Hamm R; Yan W; Taya Y; Lozano G
    Oncogene; 2000 Jan; 19(3):358-64. PubMed ID: 10656682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of the DNA-dependent protein kinase by RNA polymerase II transcriptional activator proteins.
    Peterson SR; Jesch SA; Chamberlin TN; Dvir A; Rabindran SK; Wu C; Dynan WS
    J Biol Chem; 1995 Jan; 270(3):1449-54. PubMed ID: 7836414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carboxyl-terminal transactivation domain of human serum response factor contains DNA-activated protein kinase phosphorylation sites.
    Liu SH; Ma JT; Yueh AY; Lees-Miller SP; Anderson CW; Ng SY
    J Biol Chem; 1993 Oct; 268(28):21147-54. PubMed ID: 8407951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cleavage at the carboxyl-terminus of Ku80 during apoptosis in human Jurkat T cells.
    Kato M; Nonaka T; Imajoh-Ohmi S
    J Biochem; 2005 Jun; 137(6):685-92. PubMed ID: 16002990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of p53 binding to Holliday junctions and 3-cytosine bulges by phosphorylation events.
    Subramanian D; Griffith JD
    Biochemistry; 2005 Feb; 44(7):2536-44. PubMed ID: 15709766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription by RNA polymerase II in DNA-PK deficient scid mouse cells.
    Sheppard HM; Liu X
    Biochim Biophys Acta; 2000 Sep; 1493(1-2):41-7. PubMed ID: 10978505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.